SELLAS Life Sciences is at the center of a debate over its event-driven Phase 3 REGAL trial for GPS in AML CR2 patients. The ...

Akebia Therapeutics' Vafseo adoption accelerates, but profitability remains distant amid Auryxia's decline. Read why AKBA ...

The late biologist Ray Peat once warned of seed oils and cortisol spikes on his obscure blog. He’s since become a ...

New York Post may receive revenue from affiliate and advertising partnerships for sharing this content and/or when you make a purchase. Could aging be optional? According to renowned biological aging ...

One in three men will experience moderate to severe lower urinary tract symptoms in their lifetime, with symptoms including ...

On July 2, 2026, the U.S. Food and Drug Administration (FDA) approved the use of wilate ® (von Willebrand Factor/Coagulation ...

Arrow Finance price prediction is trending fast as ARROW rallies hard on CDP mainnet news, a fresh MEXC futures listing, and ...

Objectives This study aimed to evaluate the knowledge, attitudes and practices (KAP) of Jordanian women regarding post-mastectomy breast reconstruction (PMBR), and to recognise key sociodemographic ...

NASDAQ: IMNN Host: Hello and welcome to the Life Sciences Investor Forum. On behalf of OTC Markets and our co-host, Zacks Small Cap Research, we are very pleased you've joined us. The next ...

Zendaya’s Chani is not happy with Timothée Chalamet’s Paul Atreidies, who “promised” her that he would never “take power in [his] name.” Jason Momoa‘s Duncan Idaho remarks how the Lisan al-Gaib has ...

Prostate cancer is one of the most common cancers affecting men worldwide. However, planning personalized radiotherapy in the ...

Obsidian Entertainment saw its share of layoffs and is going through massive changes, one of which reportedly involves making ...